Cognizant

Articles

Here are three mindsets for pharma companies to adopt now to reap the rewards of early action in the metaverse.

In life sciences, the metaverse opportunity knocks

Deliver designs aimed at improved clinical outcomes, not just a “feel good” user interface.

Patient-centered design: where science and empathy merge

Venu Mallarapu is a Senior Director of Life Sciences and Global Head for the Cognizant R&D Solutions Group. In his role, he is responsible for taking Cognizant’s R&D service offerings to clients across the globe. He is a trusted advisor and strategic partner to address clients’ challenges and realize their vision, goals and objectives.

Venu also manages multiple strategic partnerships with leading R&D platform vendors. He has over 23 years’ experience in business and IT advisory, strategic consulting, relationship and delivery management, with 15+ years of experience in life sciences R&D. He is a subject matter expert and thought leader in clinical, regulatory, quality and safety & pharmacovigilance functions. He has delivered strategy & transformation advisory consulting to top global pharma, biotech, vaccine and medical devices clients.

Venu has been a speaker at various life sciences and tech industry events and is a recognized thought leader in R&D with published articles. He is also an occasional blogger through his personal “Living on the Edge” blog.

https://www.linkedin.com/in/venugopalmallarapu/

Here’s how pharma businesses can speed the handling of adverse events, reduce costs, improve patient safety and spur growth through pharmacovigilance automation.

Five Steps for Automating the Pharmacovigilance Process

Moira (she/her) is a medical anthropologist, bioethicist, and policy expert with over ten years of experience in health care research and evidence-based strategic consulting. She leverages her training as a public health professional and former multi-site clinical trials coordinator to deliver innovated research emphasizing actionable insights.

Moira earned a PhD in Medical Anthropology from Northwestern University, an MPH from Northwestern Feinberg School of Medicine, and a BA in Anthropology from Brown University. Her work has been covered by Technology Today, Consumer Affairs, Everyday Health and a number of academic publications.

Front-Line Insight: How to Improve Clinical Trial Recruitment and Retention 

Bryan McSwiney is Global Director of Technical Operations for Zenith Technologies, a Cognizant Company. Bryan has over 25 years’ experience in the life sciences sector and has worked with Zenith since 1999. He has held a variety of roles over that timeframe across engineering, project management, sales and key account management, operations, country management and regional director and business P&L.

A significant portion of Bryan’s career to date has been in an international environment. He previously led Zenith’s entry into the Asian market, where he was based prior to returning to Ireland to take up his current role. Bryan can be reached at 

Here are four ways life sciences organizations can quickly and cost-effectively achieve Manufacturing 4.0 benefits while still getting treatments to market.

How Life Sciences Can Move to Manufacturing 4.0 While Meeting Market Demands

We innovate to find a better way-for the clients who depend on us, the customers who rely on them and the communities who count on us all.

The rapid spread of COVID-19 across the globe highlights the absolute need for preparedness in the face of pandemics in order to reduce and eliminate the emergence of new cases and quickly create treatment options for emerging illnesses and diseases. 